Catalytic life of activated factor XIII in thrombi. Implications for fibrinolytic resistance and thrombus aging.

scientific article published in September 2000

Catalytic life of activated factor XIII in thrombi. Implications for fibrinolytic resistance and thrombus aging. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/01.CIR.102.10.1151
P698PubMed publication ID10973845

P2093author name stringReed GL
Houng AK
Robinson BR
P433issue10
P407language of work or nameEnglishQ1860
P304page(s)1151-1157
P577publication date2000-09-01
P1433published inCirculationQ578091
P1476titleCatalytic life of activated factor XIII in thrombi. Implications for fibrinolytic resistance and thrombus aging.
P478volume102

Reverse relations

cites work (P2860)
Q34221338Alpha2-antiplasmin plays a significant role in acute pulmonary embolism
Q50012205Biomedical 19F MRI Using Perfluorocarbons
Q41825512Coagulation factor XIIIa substrates in human plasma: identification and incorporation into the clot
Q39262658Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli
Q64097553Control of fibrinolytic drug injection via real-time ultrasonic monitoring of blood coagulation
Q37899674Factor XIII: a coagulation factor with multiple plasmatic and cellular functions
Q35023065Functional factor XIII-A is exposed on the stimulated platelet surface
Q34107034Incorporation of albumin fusion proteins into fibrin clots in vitro and in vivo: comparison of different fusion motifs recognized by factor XIIIa.
Q43018362Microvascular thrombosis, fibrinolysis, ischemic injury, and death after cerebral thromboembolism are affected by levels of circulating α2-antiplasmin
Q41904806Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysis
Q64238287Molecular Imaging of Factor XIII Activity for the Early Detection of Mouse Coronary Microvascular Disease
Q35987760Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy
Q49103584Near-infrared fluorescent imaging of cerebral thrombi and blood-brain barrier disruption in a mouse model of cerebral venous sinus thrombosis
Q38801273Newly-Recognized Roles of Factor XIII in Thrombosis
Q58816212Novel Factor XIII Probes for Blood Coagulation Imaging
Q38838336Revisiting the mechanism of coagulation factor XIII activation and regulation from a structure/functional perspective
Q36664166Roles of transglutaminases in cardiac and vascular diseases
Q36655973Streptokinase--the drug of choice for thrombolytic therapy
Q35411223Substantial potential for reductions in coronary heart disease mortality in the UK through changes in risk factor levels
Q49265874The evolution of fibrin-specific targeting strategies
Q37729836Will molecular optical imaging have clinically important roles in stroke management, and how?

Search more.